Cisplatin-induced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas Fas ligand system

被引:54
作者
Razzaque, MS
Koji, T
Kumatori, A
Taguchi, T
机构
[1] Nagasaki Univ, Sch Med, Dept Pathol 2, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Sch Med, Dept Anat 3, Nagasaki 852, Japan
[3] Inst Trop Med, Dept Biochem, Nagasaki, Japan
关键词
D O I
10.1007/s004180050368
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The role of Fas and Fas ligand (Fas-L) in the apoptotic cell death process in cisplatin (CP)-treated human proximal tubular epithelial cells (PTECs) was examined. The human PTECs were treated with various concentrations (20-80 mu M) of CP for 24 h, and the incidence of apoptosis in CP-treated cells was assessed by trypan blue staining, propidium iodide staining, in situ end labeling, and electron microscopy. The expression of Fas and Fas-L was detected by immunofluorescence microscopy. The results showed that: (1) CP-treatment resulted in a decreased number of Live human PTECs and an increased number of dead cells, (2) CP-treated human PTECs showed an increased rate of apoptosis with its typical morphological features, and (3) expression of both Fas and Fas-L was upregulated in CP-treated human PTECs. These results indicate that CP treatment induces apoptosis in human PTECs and the activation of the Fas/Fas-L system may play an active role in the induction of the apoptotic cell death process.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 24 条
[1]   A HISTOCHEMICAL APPROACH TO THE MECHANISM OF ACTION OF CISPLATIN AND ITS ANALOGS [J].
AGGARWAL, SK .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1993, 41 (07) :1053-1073
[2]   SUBCELLULAR-LOCALIZATION OF CIS-DICHLORODIAMMINEPLATINUM(II) IN RAT-KIDNEY AND LIVER [J].
CHOIE, DD ;
DELCAMPO, AA ;
GUARINO, AM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 55 (02) :245-252
[3]  
COLES HSR, 1993, DEVELOPMENT, V118, P777
[4]   Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA [J].
Dixit, M ;
Yang, JL ;
Poirier, MC ;
Price, JO ;
Andrews, PA ;
Arteaga, CL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (05) :365-373
[5]   CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER [J].
EINHORN, LH ;
DONOHUE, J .
ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) :293-298
[6]   Comparison of apoptosis in wild-type and fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions [J].
Eischen, CM ;
Kottke, TJ ;
Martins, LM ;
Basi, GS ;
Tung, JS ;
Earnshaw, WC ;
Leibson, PJ ;
Kaufmann, SH .
BLOOD, 1997, 90 (03) :935-943
[7]  
EVANS DL, 1993, CANCER RES, V53, P2133
[8]  
Fulda S, 1997, CANCER RES, V57, P3823
[9]  
GOBE GC, 1987, LAB INVEST, V56, P273
[10]   THE NEPHROTOXICITY OF CISPLATIN [J].
GOLDSTEIN, RS ;
MAYOR, GH .
LIFE SCIENCES, 1983, 32 (07) :685-690